RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEACF96EE4CD6A96F4B
SubjectPredicateObject
ripekg:evaluation/RIPEACF96EE4CD6A96F4B prov:used ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B rdf:type owl:Thing
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B prov:wasMemberOf ripekg:research-integrity-assessment/RIPEACF96EE4CD6A96F4B
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:concerns ripekg:work/10.1136%2Fbmjopen-2024-093167Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:concerns ripekg:work/10.1136%2Fbmjopen-2024-093167Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:recruitmentEndDateExtractionRationale No recruitment_finish date found.
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:recruitmentStartDate 21-06-2024
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:recruitmentStartDateExtractionRationale Planned study dates: 'the expected recruitment start date was 21 June 2024'.
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:studyEndDate 21-04-2025
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B ripe:studyEndDateExtractionRationale Planned study dates: 'the expected end date was 21 April 2025'.
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B tido:supports ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-2-2
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B tido:supports ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-inspectai-2-2